Baseline metabolic panels, thyroid function, liver enzymes, HbA1c, and lipids all matter before you start, and they all need to be tracked during treatment
The form typically includes patient information, medication details, and the prescribing physician's information
The broader TRIUMPH clinical trial program has enrolled more than 5,800 participants across studies examining retatrutide for obesity, overweight, obstructive sleep apnea, knee osteoarthritis, chronic low back pain, cardiovascular and renal outcomes, and metabolic dysfunction-associated steatotic liver disease
Mounjaro secures its approval for managing type 2 diabetes, making it essential for diabetes care
Then the FDA filing, then a likely launch around 2027
This is not an argument against retatrutide it's an argument for honest timelines